2018
DOI: 10.1038/s41598-018-25294-y
|View full text |Cite
|
Sign up to set email alerts
|

Paraneoplastic limbic encephalitis associated with lung cancer

Abstract: Paraneoplastic limbic encephalitis (PLE) is a rare autoimmune neurological syndrome observed in lung cancer patients. We retrospectively investigated the clinical characteristics, treatment responses, and prognoses in 16 PLE patients who were subsequently diagnosed with lung cancer. Fifteen patients initially presented with disturbance of consciousness, 13 with disorientation, and 12 with seizures. Thirteen patients had autoantibodies, including eight with gamma aminobutyric acid B receptor (GABABR) antibodies… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
35
0
4

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(40 citation statements)
references
References 29 publications
1
35
0
4
Order By: Relevance
“…For all antibody-defined AIE subgroups combined, we could identify 116 publications that matched our search criteria and contained relevant information for the intended analyses. Ten were identified for AIE with AMPAR antibodies (716), 15 for CASPR2 (1630), eight for DPPX (3138), four for GABA A R (15, 3941) with patients reported by the Pettingil et al being excluded as these were not tested for GABA A R antibodies in CSF and represented a different phenotype (42), 15 for GABA B R antibodies (12, 15, 16, 4354), 15 for GAD antibodies (19, 22, 5567), five for GlyR antibodies (6872), 14 for IgLON5 antibodies (7386), 25 for LGI1 antibodies (5, 6, 15, 16, 1922, 30, 52, 77, 87100), and finally 27 for NMDAR antibodies (4, 15, 16, 19, 22, 52, 62, 88, 89, 101118). The history of the data search and the results are depicted in Figure 1.…”
Section: Resultsmentioning
confidence: 99%
“…For all antibody-defined AIE subgroups combined, we could identify 116 publications that matched our search criteria and contained relevant information for the intended analyses. Ten were identified for AIE with AMPAR antibodies (716), 15 for CASPR2 (1630), eight for DPPX (3138), four for GABA A R (15, 3941) with patients reported by the Pettingil et al being excluded as these were not tested for GABA A R antibodies in CSF and represented a different phenotype (42), 15 for GABA B R antibodies (12, 15, 16, 4354), 15 for GAD antibodies (19, 22, 5567), five for GlyR antibodies (6872), 14 for IgLON5 antibodies (7386), 25 for LGI1 antibodies (5, 6, 15, 16, 1922, 30, 52, 77, 87100), and finally 27 for NMDAR antibodies (4, 15, 16, 19, 22, 52, 62, 88, 89, 101118). The history of the data search and the results are depicted in Figure 1.…”
Section: Resultsmentioning
confidence: 99%
“…Onconeural antibodies associated with paraneoplastic LE are Ma, Hu, Ri, CRMP5, and SOX1 [ 66 , 145 ], with Ma2 being the major intracellular antibody causing paraneoplastic LE [ 146 ]. In paraneoplastic LE associated with lung cancer, Hu and cell surface GABA-BR antibodies were the most frequently encountered antibodies, whereas in paraneoplastic LE associated with testicular tumor, Ma2 antibody is the most frequent antibody [ 147 , 148 ].…”
Section: Intracellular Antibodiesmentioning
confidence: 99%
“…The diagnosis must be supported by the identification of specific neuronal autoantibodies [6]. The management is complex and based on a multidisciplinary and combined approach of immunotherapy and specific anticancer treatment [726]. The prognosis is usually poor and strictly related to the subtype of neuronal autoantibodies, clinical patient’s status and comorbidities, and cancer characteristics and stage [2426].…”
Section: Introductionmentioning
confidence: 99%